Frankfurt - Delayed Quote EUR

Beijing Tong Ren Tang Chinese Medicine Company Limited (TQR.F)

1.1200 +0.0200 (+1.82%)
At close: April 26 at 8:00 AM GMT+2
Key Events
Loading Chart for TQR.F
DELL
  • Previous Close 1.1000
  • Open 1.1200
  • Bid 1.1400 x 780000
  • Ask 1.1600 x 780000
  • Day's Range 1.1200 - 1.1200
  • 52 Week Range 1.0300 - 1.8900
  • Volume 900
  • Avg. Volume 62
  • Market Cap (intraday) 956.983M
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) 14.00
  • EPS (TTM) 0.0800
  • Earnings Date --
  • Forward Dividend & Yield 0.04 (3.45%)
  • Ex-Dividend Date Jun 4, 2024
  • 1y Target Est --

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. Beijing Tong Ren Tang Chinese Medicine Company Limited was founded in 1669 and is based in Wan Chai, Hong Kong.

www.tongrentangcm.com

798

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TQR.F

Performance Overview: TQR.F

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TQR.F
19.42%
HANG SENG INDEX
3.54%

1-Year Return

TQR.F
25.33%
HANG SENG INDEX
10.03%

3-Year Return

TQR.F
115.63%
HANG SENG INDEX
39.30%

5-Year Return

TQR.F
389.00%
HANG SENG INDEX
40.27%

Compare To: TQR.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TQR.F

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    956.99M

  • Enterprise Value

    689.42M

  • Trailing P/E

    14.47

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.16

  • Price/Book (mrq)

    2.04

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    0.89

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    35.44%

  • Return on Assets (ttm)

    8.98%

  • Return on Equity (ttm)

    15.22%

  • Revenue (ttm)

    1.52B

  • Net Income Avi to Common (ttm)

    540.39M

  • Diluted EPS (ttm)

    0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.4B

  • Total Debt/Equity (mrq)

    3.28%

  • Levered Free Cash Flow (ttm)

    317.64M

Company Insights: TQR.F

People Also Watch